Effects Of Optimized Blinking Training on Visual Function and Tear Film Parameters in Individuals With CVS
1 other identifier
interventional
52
1 country
1
Brief Summary
"Computer vision syndrome (CVS), refers to a range of eye and vision issues caused by extended use of computers, tablets, e-readers, and smartphones. Computer users experience visual symptoms, such as eyestrain, headaches, eye discomfort, dry eyes, double vision, and blurred vision, especially after long periods of looking at screens, whether up close or at a distance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 20, 2025
CompletedFirst Submitted
Initial submission to the registry
March 29, 2025
CompletedFirst Posted
Study publicly available on registry
April 6, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 20, 2026
CompletedApril 6, 2025
March 1, 2025
3 months
March 29, 2025
March 29, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Computer Vision Syndrome (CVS-Q)
The Computer Vision Syndrome Questionnaire (CVS-Q) assesses the frequency and intensity of 16 ocular and visual symptoms related to prolonged screen use, with a total score of 6 or more indicating CVS If the total score is ≥6 points, the individual is considered to suffer Computer Vision Syndrome
12 Months
Study Arms (2)
Grouyp 1 (without blinking exercises).
ACTIVE COMPARATOREXP group (Routine CVS treatment)
EXPERIMENTALInterventions
Group B (Control Group) The control group will continue receiving only the routine rehabilitation (without blinking exercises). Routine rehabilitation included the 20-20-20 rule, blue light-blocking glasses, and polyvinyl alcohol eye drops.
"Group A (Experimental Group): Individuals in the Experimental group will receive Routine CVS treatment with optimized blinking exercise. Routine rehabilitation includes the 20-20-20 rule, blue light-blocking glasses, and polyvinyl eye drops. The blinking exercise involved the individuals looking at an object 6 meters away for 5 seconds, followed by complete eyelid closure for 5 seconds. This cycle was repeated for 5 minutes, twice a day."
Eligibility Criteria
You may qualify if:
- Individuals aged 18-40 years who work on computers or digital devices for at least 3 to 6 hours daily.
- Both Male and Female.
- Individuals who could undergo a complete ocular examination.
- Presence of symptoms consistent with digital eye strain.
- Presented with eye complaints such as eye fatigue, burning, irritation, redness, and blurred vision due to long-term computer or digital screen use.
- Symptoms worsened during exposure to digital screen light.
You may not qualify if:
- Use of medications that might influence tear production or ocular surface status (e.g., antihistamines, antidepressants).
- Diagnosed neurological or systemic conditions that impact vision or blink patterns (e.g., Parkinson's disease, multiple sclerosis).
- Individual's with a history of ocular surface diseases such as conjunctivitis or keratitis.
- History of any psychiatric diagnosis."
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ramzan Eye Care and Optix Khudian Khas
Kasur, Punjab Province, Pakistan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 29, 2025
First Posted
April 6, 2025
Study Start
March 20, 2025
Primary Completion
June 20, 2025
Study Completion
February 20, 2026
Last Updated
April 6, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share